Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Optimal strategies for the treatment of metastatic triple-negative breast cancer with currently approved agents.

André F, Zielinski CC.

Ann Oncol. 2012 Aug;23 Suppl 6:vi46-51. Review.

PMID:
23012302
2.

Characteristics of triple-negative breast cancer.

de Ruijter TC, Veeck J, de Hoon JP, van Engeland M, Tjan-Heijnen VC.

J Cancer Res Clin Oncol. 2011 Feb;137(2):183-92. doi: 10.1007/s00432-010-0957-x. Review.

3.

Molecularly targeted therapies for metastatic triple-negative breast cancer.

Bayraktar S, Glück S.

Breast Cancer Res Treat. 2013 Feb;138(1):21-35. doi: 10.1007/s10549-013-2421-5. Review.

PMID:
23358903
4.

Emerging targeted therapies in triple-negative breast cancer.

Crown J, O'Shaughnessy J, Gullo G.

Ann Oncol. 2012 Aug;23 Suppl 6:vi56-65. Review.

PMID:
23012305
5.

[Triple-negative breast cancer: histoclinical and molecular features, therapeutic management and perspectives].

Gonçalves A, Sabatier R, Charafe-Jauffret E, Gilabert M, Provansal M, Tarpin C, Extra JM, Viens P, Bertucci F.

Bull Cancer. 2013 May;100(5):453-64. doi: 10.1684/bdc.2013.1740. Review. French.

PMID:
23695030
7.

Treatment outcomes and clinicopathologic characteristics of triple-negative breast cancer patients who received platinum-containing chemotherapy.

Uhm JE, Park YH, Yi SY, Cho EY, Choi YL, Lee SJ, Park MJ, Lee SH, Jun HJ, Ahn JS, Kang WK, Park K, Im YH.

Int J Cancer. 2009 Mar 15;124(6):1457-62. doi: 10.1002/ijc.24090.

8.

Management of triple negative breast cancer.

Oakman C, Viale G, Di Leo A.

Breast. 2010 Oct;19(5):312-21. doi: 10.1016/j.breast.2010.03.026. Review.

PMID:
20382530
9.

Triple-negative breast cancer: role of specific chemotherapy agents.

Isakoff SJ.

Cancer J. 2010 Jan-Feb;16(1):53-61. doi: 10.1097/PPO.0b013e3181d24ff7. Review.

10.

Metastatic triple-negative breast cancer.

Rakha EA, Chan S.

Clin Oncol (R Coll Radiol). 2011 Nov;23(9):587-600. doi: 10.1016/j.clon.2011.03.013. Review.

PMID:
21524569
11.

Adjuvant treatments for triple-negative breast cancers.

Joensuu H, Gligorov J.

Ann Oncol. 2012 Aug;23 Suppl 6:vi40-5. Review.

PMID:
23012301
12.

Triple-negative breast cancer: advancements in characterization and treatment approach.

Hurvitz S, Mead M.

Curr Opin Obstet Gynecol. 2016 Feb;28(1):59-69. doi: 10.1097/GCO.0000000000000239. Review.

PMID:
26694831
13.

Triple-negative breast cancer: an unmet medical need.

Hudis CA, Gianni L.

Oncologist. 2011;16 Suppl 1:1-11. doi: 10.1634/theoncologist.2011-S1-01. Review.

14.

Triple-negative breast cancer--current status and future directions.

Gluz O, Liedtke C, Gottschalk N, Pusztai L, Nitz U, Harbeck N.

Ann Oncol. 2009 Dec;20(12):1913-27. doi: 10.1093/annonc/mdp492. Review.

PMID:
19901010
15.

Updates in the treatment of basal/triple-negative breast cancer.

Shastry M, Yardley DA.

Curr Opin Obstet Gynecol. 2013 Feb;25(1):40-8. doi: 10.1097/GCO.0b013e32835c1633. Review.

PMID:
23222093
16.

Promising therapeutic options in triple-negative breast cancer.

Bilici A, Arslan C, Altundag K.

J BUON. 2012 Apr-Jun;17(2):209-22. Review.

PMID:
22740196
17.

Current treatment options in triple negative breast cancer.

Rodler E, Korde L, Gralow J.

Breast Dis. 2010;32(1-2):99-122. doi: 10.3233/BD-2010-0304. Review.

PMID:
21778572
18.

Clinical trials in triple negative breast cancer.

Reeder-Hayes KE, Carey LA, Sikov WM.

Breast Dis. 2010;32(1-2):123-36. doi: 10.3233/BD-2010-0310. Review.

PMID:
21778571
19.

Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer.

Liedtke C, Mazouni C, Hess KR, André F, Tordai A, Mejia JA, Symmans WF, Gonzalez-Angulo AM, Hennessy B, Green M, Cristofanilli M, Hortobagyi GN, Pusztai L.

J Clin Oncol. 2008 Mar 10;26(8):1275-81. doi: 10.1200/JCO.2007.14.4147.

PMID:
18250347
20.

Second-line bevacizumab-containing therapy in patients with triple-negative breast cancer: subgroup analysis of the RIBBON-2 trial.

Brufsky A, Valero V, Tiangco B, Dakhil S, Brize A, Rugo HS, Rivera R, Duenne A, Bousfoul N, Yardley DA.

Breast Cancer Res Treat. 2012 Jun;133(3):1067-75. doi: 10.1007/s10549-012-2008-6.

PMID:
22415477

Supplemental Content

Support Center